Skip to main content

Day: August 24, 2022

Nokia Corporation: Repurchase of own shares on 24.08.2022

Nokia CorporationStock Exchange Release24 August 2022 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 24.08.2022 Espoo, Finland – On 24 August 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 200,935 4.95CEUX 24,163 4.95AQEU 11,869 4.95TQEX 8,033 4.95Total 245,000 4.95* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Continue reading

Vanguard Announces Cash Distributions for the Vanguard ETFs (VAB, VSB, VSC, VLB, VCB, VGV, VRIF, VRE and VDY)

TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) — Vanguard Investments Canada Inc. today announced the final August 2022 cash distributions for certain Vanguard ETFs, listed below, that trade on Toronto Stock Exchange (TSX). Unitholders of record on September 01, 2022 will receive cash distributions payable on September 09, 2022. Details of the “per unit” distribution amounts are as follows:  Vanguard ETF® TSX Ticker Symbol Distribution per Unit ($) CUSIP ISIN Payment FrequencyVanguard Canadian Aggregate Bond Index ETF VAB 0.057448 92203E101 CA92203E1016 MonthlyVanguard Canadian Short-Term Bond Index ETF VSB 0.047281 92203G106 CA92203G1063 MonthlyVanguard Canadian Short-Term Corporate Bond Index ETF VSC 0.060058 92203N101 CA92203N1015 MonthlyVanguard Canadian Long-Term Bond Index ETF VLB 0.070817 92211H104 CA92211H1047 MonthlyVanguard...

Continue reading

Pokemoto Opens First Mississippi Location

Oxford, MS Pokemoto Hawaiian Poke Bowl RestaurantPokemoto Opens in Oxford, Home of University of Mississippi Burleson, Texas, Aug. 24, 2022 (GLOBE NEWSWIRE) — Pokemoto, Muscle Maker, Inc.’s (Nasdaq: GRIL) expanding Hawaiian poke bowl restaurant concept, today announced the grand opening of its first Mississippi franchise location in Oxford, Mississippi. The opening marks the first of three previously inked franchise deals in the Mississippi market. Being near “Ole Miss” provides exposure to Pokemoto’s core targeted audience – Millennials and Gen Zs. The location features Pokemoto’s brand new interior graphic design package, signage and menu items. “We are very excited to be opening our first Pokemoto location in Mississippi, especially in Oxford – the home of the University of Mississippi. This opening marks one of our...

Continue reading

InvestmentPitch Media Video Discusses Kintavar Exploration’s Drilling Program on the Wabash Project in Quebec where Surface Channel Samples Returned 0.71% Cu, 30.1 g/t Ag, 0.23% Pb and 0.16% Zn over 12.7m

VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (TSXV:KTR) completed the summer drilling program on the MLI corridor and released additional results from its surface exploration program on the Wabash project. Its 100% owned flagship project, the Mitchi–Wabash copper-silver district, is located 100 km north of the town of Mont-Laurier and 15 km East of the town of Parent in Quebec. A Media Snippet accompanying this announcement is available by selecting the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch.com” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Kintavar” in the search...

Continue reading

Oxurion To Present at Upcoming Scientific and Investor Conferences

Leuven, BELGIUM, Boston, MA, US – August 24, 2022 – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced that it will participate in three upcoming conferences. 22ndEURETINA Congress – Hamburg, GermanyDate: Friday, September 2, 2022 | 12:15 p.m. CET   Title: “Results of Part A of KALAHARI, a Phase 2 Trial of THR-149, a plasma kallikrein (pKal) inhibitor, for the treatment of diabetic macular edema (DME)” presented by Timothy L. Jackson, MD. H.C. Wainwright & Co., 24thAnnual Global Investment Conference – New York, NY & Virtual Date: Monday, September 12, 2022 | 7:00 a.m. ET Tom Graney, CEO of Oxurion, will deliver a virtual presentation and is available for one-on-one meetings.   KBC...

Continue reading

Proactive news headlines including Snowline Gold, American Manganese, Mednow, DRDGOLD, NEXE Innovations, Mountain Boy Minerals and EverGen Infrastructure

New York , Aug. 24, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Real Luck Group posts strong balance sheet, lays out growth plans in 2Q results click here MySize and Santista Textil create joint venture to serve Brazilian apparel market with sizing technology and sustainability solutions for retailers click here TNR Gold kicks off exploration at Shotgun Gold Project in Alaska click here BetterLife Pharma says new study on LSD confirms the cognitive effects of its analog drug BETR-001 click here Nextleaf Solutions launches first THC-free CBD drops under the Glacial Gold brand click here Star Royalties sees record 2Q revenue as Elk Gold Mine turns into producing royalty asset; gains $18.6M on deconsolidation...

Continue reading

AB Science announces that it has filed an application for conditional Marketing Authorization to EMA for masitinib in the treatment of ALS

PRESS RELEASE AB SCIENCE ANNOUNCES FILING OF MARKETING AUTHORIZATION APPLICATION FOR ALSITEK IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND ITS VALIDATION BY THE EUROPEAN MEDICINES AGENCY (EMA) Paris, 24 August 2022, 7pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that it has filed an application for conditional Marketing Authorization to the European Medicines Agency (EMA) for Alsitek (masitinib) in the treatment of amyotrophic lateral sclerosis (ALS). This application has now been validated by EMA and review by the Committee for Medicinal Products for Human Use (CHMP) has begun. The CHMP has a target of 210 active evaluation days to review the application. The application is based on results from the phase 2/3 AB10015 study and its long-term survival follow-up. Study AB10015 was a randomized,...

Continue reading

Norsk Hydro: Labor dispute between Industri Energi and Norsk Industri has ended

Industri Energi and Norsk Industri have today agreed on a solution to the labor dispute regarding the revision of the Electrochemical Agreement. The strike at Hydro Sunndal will be called off with immediate effect. Hydro Sunndal will resume normal operations from tomorrow and shipping of products to customers will resume. Potential delays to customers are expected to be minor. Investor contact: Line Haugetraa +47 41406376Line.Haugetraa@hydro.com Media contact: Halvor Molland +47 92979797Halvor.Molland@hydro.com

Continue reading

ALSTOM SA: Results of the option to receive the 2021/22 dividend in shares

Results of the option to receive the 2021/22 dividend in shares ALSTOMSociété Anonyme with share capital of €2,616,486,292Headquarter: 48, rue Albert Dhalenne, 93400 Saint-Ouen-sur-Seine 389 058 447 R.C.S. Bobigny 24 August 2022 – The Shareholders’ Meeting of the Company, held on July 12, 2022, offered the option for shareholders to receive the 2021/22 dividend of €0.25 gross per share in cash or in new shares of the Company. The share price for the new shares to be issued in payment of the 2021/22 dividend was set on July 12, 2022 at 21.13 euros. The terms of dividend payment have been detailed in the press release of 12 July 2022. The period to exercise the option ran from July 22 to August 22, 2022 included. At the end of the option period, 55,00% of rights were exercised in favour of receiving the payment for the 2021/22 dividend...

Continue reading

Total number of shares and voting rights in the share capital as of July 31, 2022 

Total number of shares and voting rights in the share capital as of July 31, 2022 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority) Date  Total number of shares in the capital   Number of theoretical voting rights  Number of exercisable voting rights 07/31/2022  95 375 232  161 669 032 161 669 032Next on the agenda: : First half 2022 results, on September 28, 2022 (before market opening)About Voltalia (www.voltalia.com)Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind, solar, hydraulic, biomass and storage facilities that it owns and operates. Voltalia has generating capacity in operation and under construction of more than 2 GW and a portfolio of projects under...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.